| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Revenue | $4.55B | +6.0% |
| Gross Profit | $1.96B | +10.4% |
| R&D Expense | $309.0M | +7.6% |
| SG&A Expense | $164.0M | +5.8% |
| Operating Income | $654.9M | +11.5% |
| Pre-tax Income | $706.9M | +13.7% |
| Income Tax | $75.3M | +697.0% |
| Net Income | $631.5M | +3.2% |
| EPS (Basic) | $4.17 |
| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.50B | -1.2% |
| Accounts Receivable | $454.5M | -16.1% |
| Inventory | $503.7M | +19.2% |
| Current Assets | $2.59B | -1.5% |
| Total Assets | $3.54B | -1.8% |
| Current Liabilities | $1.10B | +1.4% |
| Total Liabilities | $1.41B | +2.9% |
| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $842.6M | -26.4% |
| Capital Expenditures | $56.1M | +0.4% |
| Investing Cash Flow | -$57.3M | +18.6% |
| Financing Cash Flow | -$797.4M | -15.5% |
| Free Cash Flow | $786.4M | -27.8% |
| +6.9% |
| EPS (Diluted) | $4.13 | +6.7% |
| Stockholders' Equity |
| $2.13B |
| -4.8% |